-
Je něco špatně v tomto záznamu ?
C-Geranylated flavanone diplacone enhances in vitro antiproliferative and anti-inflammatory effects in its copper(II) complexes
Z. Trávníček, J. Vančo, J. Belza, G. Zoppellaro, Z. Dvořák, B. Beláková, JA. Schmid, L. Molčanová, K. Šmejkal
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- antiflogistika farmakologie chemie MeSH
- autofagie účinky léků MeSH
- flavanony * farmakologie chemie MeSH
- komplexní sloučeniny * farmakologie chemická syntéza chemie MeSH
- lidé MeSH
- měď * chemie farmakologie MeSH
- nádorové buněčné linie MeSH
- proliferace buněk * účinky léků MeSH
- protinádorové látky * farmakologie chemie chemická syntéza MeSH
- reaktivní formy kyslíku metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Two copper(II) complexes containing diplacone (H4dipl), a naturally occurring C-geranylated flavanone derivative, in combination with bathophenanthroline (bphen) or 1,10-phenanthroline (phen) with the composition [Cu3(bphen)3(Hdipl)2]⋅2H2O (1) and {[Cu(phen)(H2dipl)2]⋅1.25H2O}n (2) were prepared and characterized. As compared to diplacone, the complexes enhanced in vitro cytotoxicity against A2780 and A2780R human ovarian cancer cells (IC50 ≈ 0.4-1.2 μM), human lung carcinoma (A549, with IC50 ≈ 2 μM) and osteosarcoma (HOS, with IC50 ≈ 3 μM). Cellular effects of the complexes in A2780 cells were studied using flow cytometry, covering studies concerning cell-cycle arrest, induction of cell death and autophagy and induction of intracellular ROS/superoxide production. These results uncovered a possible mechanism of action characterized by the G2/M cell cycle arrest. The studies on human endothelial cells revealed that complexes 1 and 2, as well as their parental compound diplacone, do possess anti-inflammatory activity in terms of NF-κB inhibition. As for the effects on PPARα and/or PPARγ, complex 2 reduced the expression of leukocyte adhesion molecules VCAM-1 and E-selectin suggesting its dual anti-inflammatory capacity. A wide variety of Cu-containing coordination species and free diplacone ligand were proved by mass spectrometry studies in water-containing media, which might be responsible for multimodal effect of the complexes.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24013290
- 003
- CZ-PrNML
- 005
- 20240905133845.0
- 007
- ta
- 008
- 240725e20240613xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.jinorgbio.2024.112639 $2 doi
- 035 __
- $a (PubMed)38880070
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Trávníček, Zdeněk $u Regional Centre of Advanced Technologies and Materials (RCPTM), Czech Advanced Technology and Research Institute (CATRIN), Palacký University, Šlechtitelů 27, 772 00 Olomouc, Czech Republic. Electronic address: zdenek.travnicek@upol.cz
- 245 10
- $a C-Geranylated flavanone diplacone enhances in vitro antiproliferative and anti-inflammatory effects in its copper(II) complexes / $c Z. Trávníček, J. Vančo, J. Belza, G. Zoppellaro, Z. Dvořák, B. Beláková, JA. Schmid, L. Molčanová, K. Šmejkal
- 520 9_
- $a Two copper(II) complexes containing diplacone (H4dipl), a naturally occurring C-geranylated flavanone derivative, in combination with bathophenanthroline (bphen) or 1,10-phenanthroline (phen) with the composition [Cu3(bphen)3(Hdipl)2]⋅2H2O (1) and {[Cu(phen)(H2dipl)2]⋅1.25H2O}n (2) were prepared and characterized. As compared to diplacone, the complexes enhanced in vitro cytotoxicity against A2780 and A2780R human ovarian cancer cells (IC50 ≈ 0.4-1.2 μM), human lung carcinoma (A549, with IC50 ≈ 2 μM) and osteosarcoma (HOS, with IC50 ≈ 3 μM). Cellular effects of the complexes in A2780 cells were studied using flow cytometry, covering studies concerning cell-cycle arrest, induction of cell death and autophagy and induction of intracellular ROS/superoxide production. These results uncovered a possible mechanism of action characterized by the G2/M cell cycle arrest. The studies on human endothelial cells revealed that complexes 1 and 2, as well as their parental compound diplacone, do possess anti-inflammatory activity in terms of NF-κB inhibition. As for the effects on PPARα and/or PPARγ, complex 2 reduced the expression of leukocyte adhesion molecules VCAM-1 and E-selectin suggesting its dual anti-inflammatory capacity. A wide variety of Cu-containing coordination species and free diplacone ligand were proved by mass spectrometry studies in water-containing media, which might be responsible for multimodal effect of the complexes.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a flavanony $x farmakologie $x chemie $7 D044950
- 650 12
- $a komplexní sloučeniny $x farmakologie $x chemická syntéza $x chemie $7 D056831
- 650 12
- $a měď $x chemie $x farmakologie $7 D003300
- 650 12
- $a proliferace buněk $x účinky léků $7 D049109
- 650 12
- $a protinádorové látky $x farmakologie $x chemie $x chemická syntéza $7 D000970
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a antiflogistika $x farmakologie $x chemie $7 D000893
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 650 _2
- $a autofagie $x účinky léků $7 D001343
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vančo, Ján $u Regional Centre of Advanced Technologies and Materials (RCPTM), Czech Advanced Technology and Research Institute (CATRIN), Palacký University, Šlechtitelů 27, 772 00 Olomouc, Czech Republic
- 700 1_
- $a Belza, Jan $u Regional Centre of Advanced Technologies and Materials (RCPTM), Czech Advanced Technology and Research Institute (CATRIN), Palacký University, Šlechtitelů 27, 772 00 Olomouc, Czech Republic
- 700 1_
- $a Zoppellaro, Giorgio $u Regional Centre of Advanced Technologies and Materials (RCPTM), Czech Advanced Technology and Research Institute (CATRIN), Palacký University, Šlechtitelů 27, 772 00 Olomouc, Czech Republic
- 700 1_
- $a Dvořák, Zdeněk $u Department of Cell Biology and Genetics, Faculty of Science, Palacký University, Šlechtitelů 27, 772 00 Olomouc, Czech Republic
- 700 1_
- $a Beláková, Barbora $u Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Center for Physiology and Pharmacology, Schwarzspanierstraße 17, A1090 Vienna, Austria
- 700 1_
- $a Schmid, Johannes A $u Institute of Vascular Biology and Thrombosis Research, Medical University of Vienna, Center for Physiology and Pharmacology, Schwarzspanierstraße 17, A1090 Vienna, Austria
- 700 1_
- $a Molčanová, Lenka $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého 1946/1, 612 00 Brno, Czech Republic
- 700 1_
- $a Šmejkal, Karel $u Department of Natural Drugs, Faculty of Pharmacy, Masaryk University, Palackého 1946/1, 612 00 Brno, Czech Republic
- 773 0_
- $w MED00006646 $t Journal of inorganic biochemistry $x 1873-3344 $g Roč. 258 (20240613), s. 112639
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38880070 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905133839 $b ABA008
- 999 __
- $a ok $b bmc $g 2143237 $s 1225156
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 258 $c - $d 112639 $e 20240613 $i 1873-3344 $m Journal of inorganic biochemistry $n J Inorg Biochem $x MED00006646
- LZP __
- $a Pubmed-20240725